Advances in axillary surgery for breast cancer 2019.
Over the last 25 years, modifications in systemic and radiation therapy for breast cancer have led to significant reductions in the risk of regional recurrence. During the same time, surgeons have demonstrated that it is safe to forego axillary dissections for patients with low burdens of axillary lymph node disease. When these advances are added to those by reconstructive microsurgeons, the promise of reducing morbidity rates from posttreatment lymphedema seems within our grasp.
['Sener|Stephen F|SF|http://orcid.org/0000-0003-4966-1670']
D001365:Axilla D001943:Breast Neoplasms D005260:Female D006801:Humans D008197:Lymph Node Excision D008198:Lymph Nodes D008207:Lymphatic Metastasis D009364:Neoplasm Recurrence, Local D016032:Randomized Controlled Trials as Topic
lymphedema axillary radiation axillary reverse mapping neoadjuvant therapy sentinel lymph node